Literature DB >> 27463221

Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.

Tomoyuki Isobe1,2, Taku Kasai1, Hiroyuki Kawai1.   

Abstract

PURPOSE: We evaluated the ocular pharmacokinetics of ripasudil (K-115), a selective Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor, following topical administration to rabbits.
METHODS: We determined the ocular distribution of [(14)C]ripasudil by whole-head autoradiography and the radioactivity of each ocular tissue after single and multiple instillation of [(14)C]ripasudil to pigmented rabbits. We also measured the aqueous humor concentrations after concomitant instillation of ripasudil and a combination agent (0.005% latanoprost and 0.5% timolol) to pigmented rabbits as well as the tear fluid concentrations after instillation into rabbits, dogs, and monkeys using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Membrane permeability was evaluated using an in vitro parallel artificial membrane permeability assay system and Ussing chamber with rabbit cornea and conjunctiva.
RESULTS: [(14)C]Ripasudil was rapidly absorbed into the cornea and distributed throughout the eye after topical instillation. The melanin-containing ocular tissues, such as the iris-ciliary body and retina-choroid, showed much higher concentrations of radioactivity than the other nonpigmented tissues. Concomitant instillation showed minor effects on the aqueous humor concentrations of each compound in rabbits. Membrane permeability of ripasudil was higher than other glaucoma drugs in vitro and ex vivo. The aqueous humor concentrations of ripasudil in rabbits were higher than those in dogs and monkeys in the early period after instillation and associated with tear turnover rate.
CONCLUSIONS: These results indicate favorable intraocular penetration characteristics of ripasudil following topical administration.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27463221     DOI: 10.1089/jop.2016.0028

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  8 in total

1.  Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.

Authors:  Yusuke Ohta; Sanae Takaseki; Takeshi Yoshitomi
Journal:  Jpn J Ophthalmol       Date:  2017-06-26       Impact factor: 2.447

2.  Rho-Kinase Inhibition Reduces Myofibroblast Differentiation and Proliferation of Scleral Fibroblasts Induced by Transforming Growth Factor β and Experimental Glaucoma.

Authors:  Ian Pitha; Ericka Oglesby; Amanda Chow; Elizabeth Kimball; Mary Ellen Pease; Julie Schaub; Harry Quigley
Journal:  Transl Vis Sci Technol       Date:  2018-11-14       Impact factor: 3.283

3.  Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine.

Authors:  Etsuo Chihara; Galina Dimitrova; Tomoyuki Chihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-08       Impact factor: 3.117

4.  Effect of ripasudil on diabetic macular edema.

Authors:  Yoshiro Minami; Young-Seok Song; Akihiro Ishibazawa; Tsuneaki Omae; Tomoko Ro-Mase; Satoshi Ishiko; Akitoshi Yoshida
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

5.  Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells.

Authors:  Wenshi Chen; Xuejiao Yang; Jingwang Fang; Yuqing Zhang; Wei Zhu; Xian Yang
Journal:  Front Pharmacol       Date:  2020-03-17       Impact factor: 5.810

6.  Novel immunotherapeutic effects of topically administered ripasudil (K-115) on corneal allograft survival.

Authors:  Takenori Inomata; Keiichi Fujimoto; Yuichi Okumura; Jun Zhu; Kenta Fujio; Hurramhon Shokirova; Maria Miura; Mikiko Okano; Toshinari Funaki; Jaemyoung Sung; Naoko Negishi; Akira Murakami
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.379

Review 7.  Remodeling of the Lamina Cribrosa: Mechanisms and Potential Therapeutic Approaches for Glaucoma.

Authors:  Ryan G Strickland; Mary Anne Garner; Alecia K Gross; Christopher A Girkin
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

8.  Reticular epithelial corneal edema as a novel side-effect of Rho Kinase Inhibitors: An Indian scenario.

Authors:  Mona Bhargava; Surajit Sen; Varsha Bhambhani; Raj Shekhar Paul; Chandana Dutta
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.